AzTrials
AzTrials

Dental CariesNCT05437432

Esthetic Evaluation of Onlay Restorations Constructed From Vita Ambria Glass Ceramics

A study testing VITA AMBRIA and IPS e.max press in people with Dental Caries, run by Al-Azhar University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is limited data available on VITA AMBRIA glass ceramic , so this study is conducted to investigate the esthetic parameters of this new glass press system. Read more about this study

Who is it for?
Ages 25 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Dental Caries
What is being tested?
VITA AMBRIA and IPS e.max press
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteEgypt
Study dates
1 Mar 2022to 1 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy participants aged 18-50 years
  • Normal occlusion
  • Well-aligned teeth
  • Good oral hygiene
  • Both sexes eligible
  • Presence of one or more posterior teeth with moderate-size coronal decay or old fillings
Show all 10Show fewer
  • Target teeth:
  • No signs/symptoms of pathology
  • Complete root apex (confirmed by radiograph)
  • No fractures (confirmed by radiograph)

Who cannot join

  • Incapable of self-care
  • Mental illness
  • Undergoing radiotherapy
  • Epilepsy
  • Diabetes
  • Pregnancy or lactation
Show all 17Show fewer
  • Allergy to materials used in the study
  • Smokers
  • Parafunctional habits (e.g., bruxism)
  • Poor oral hygiene
  • Severe periodontitis
  • Teeth requiring surgical crown lengthening or marginal elevation
  • Teeth with enamel discoloration, hypoplasia, or hypocalcification
  • Malaligned or malformed teeth
  • Missing adjacent or opposing teeth
  • Third molars
  • Teeth requiring vital pulp therapy

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dental Medicine, Boys, Cairo Al-Azhar University

    Cairo, Nasr City, 11768

Other trials in Egypt

About this study

Official title: Esthetic Evaluation of Onlay Restorations Constructed From Two Types of Glass Ceramics:A Randomized Clinical Trial.

There is limited data available on VITA AMBRIA glass ceramic , so this study is conducted to investigate the esthetic parameters of this new glass press system.

Read the detailed description

This study will be randomized, double blinded, 1:1 parallel group, superiority clinical trial. including two research groups; VITA AMBRIA ( intervention) and IPS e.max press( Comprator). The total subjects in this study are 50, recruited from the faculty' out patient clinic. 50 partial coverage indirect restorations will fabricated and cemented for each subject. Clinical evaluations will be conducted at baseline, 6, and 12 months of follow-up according to FDI World Dental Federation criteria by two independent evaluators. The primary outcome is examining the color stability and translucency.

Conditions
Dental Caries
Being tested
VITA AMBRIA, IPS e.max press
Keywords
Inlay, glass cermaics, color, Translucency
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VITA AMBRIAProcedure or surgery

    Also called Zirconia-reinforced lithium disilicate glass ceramic press system

    25 onlay restroations will be fabricated from Vita-ambria glass ceramic press system.

  • IPS e.max pressProcedure or surgery

    Also called Lithium disilicate glass ceramic press system

    25 onlay restroations will be fabricated from IPS e.max glass ceramic press system.

Study groups in NCT05437432
Study groupRoleWhat they receive
Vita ambria onlay restorationExperimentalonlays constructed from zirconia-reinforced lithium disilicate glass ceramic press system
Receives: Procedure: VITA AMBRIA
e.max onlay restorationActive comparatoronlays constructed from lithium disilicate glass ceramic press system
Receives: Procedure: IPS e.max press

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Color stability and translucency

    According to FDI criteria;

    1. Color and translucency of the restoration have a clinically excellent colour match with the surrounding enamel and adjacent teeth. There is no difference in shade, brightness or translucency between restoration and tooth.
    2. Colour match is clinically acceptable but minor deviations in shade between tooth and restoration are apparent.
    3. Colour match is satisfactory; there is a clear deviation in colour match that does not affect aesthetics.
    4. Colour and/or translucency are clinically unsatisfactory. There is a localized discoloration or opaqueness in the restoration making it immediately recognizable from a speaking distance and affecting the appearance of the dentition. Partial removal and repair are possible.
    5. Colour match and/or translucency. are clinically unsatisfactory. The restoration displays an unacceptable alteration in colour and/or translucency. Restoration needs replacement.

    Measured: 12 months

Secondary outcomes (3)
  1. Surface gloss/Luster

    1.1 Luster comparable to enamel. 1.2.1 Slightly dull, not noticeable from speaking distance. 1.2.2 Some isolated pores. 1.3.1 Dull surface but acceptable if covered with film of saliva. 1.3.2 Multiple pores on more than one third of the surface. 1.4.1 Rough surface cannot be masked by saliva film, simple polishing is not sufficient. Further intervention necessary.

    1.4.2 Voids. 1.5 Very rough, unacceptable plaque retentive surface.

    Measured: 12 months

  2. Staining a. surface b. margin

    2a.1 No surface staining. 2b.1 No marginal staining. 2a.2 Minor surface staining, easily removable by polishing. 2b.2 Minor marginal staining, easily removable by polishing. 2a.3 Moderate surface staining that may also present on other teeth, not esthetically unacceptable.

    2b.3 Moderate marginal staining, not esthetically unacceptable. 2a.4 Unacceptable surface staining on the restoration and major intervention necessary for improvement.

    2b.4 Pronounced marginal staining; major intervention necessary for improvement.

    2a.5 Severe surface staining and/or subsurface staining, generalized or localized, not accessible for intervention.

    2b.5 Deep marginal staining, not accessible for intervention.

    Measured: 12 months

  3. Esthetic anatomical form

    4.1 Form is ideal. 4.2 Form is only slightly deviated from the normal. 4.3 Form deviates from the normal but is esthetically acceptable. 4.4. Form is affected and unacceptable esthetically. Intervention/correction is necessary.

    4.5 Form is unsatisfactory and/or lost. Repair not feasible / reasonable, Replacement needed.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2022
  2. Study start1 Mar 2022
  3. Primary completion1 May 2023
  4. Study completion1 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05437432
Sponsor's protocol ID
Color of Vita Ambria
Status last verified
Oct 2026
First submitted
25 Jun 2022
Last updated
28 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Azeem RA, Sureshbabu NM. Clinical performance of direct versus indirect composite restorations in posterior teeth: A systematic review. J Conserv Dent. 2018 Jan-Feb;21(1):2-9. doi: 10.4103/JCD.JCD_213_16.

    PubMed 29628639
  • Pop-Ciutrila IS, Ghinea R, Dudea D, Ruiz-Lopez J, Perez MM, Colosi H. The effects of thickness and shade on translucency parameters of contemporary, esthetic dental ceramics. J Esthet Restor Dent. 2021 Jul;33(5):795-806. doi: 10.1111/jerd.12733. Epub 2021 Apr 18.

    PubMed 33866673

Questions about this trial

What is this clinical trial studying?

A study testing VITA AMBRIA and IPS e.max press in people with Dental Caries, run by Al-Azhar University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Color stability and translucency (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05437432, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in